comprehensive -WSS

comprehensive

author：leisure time 2025-10-02 22:28:28 - browse：84332

Jacob S. Van Naarden (left), Athena Countouriotis( center), and Vlad Coric (right) on stage at the 2023 STAT Summit. — From left, Eli Lilly's Jacob S. Van Naarden, Avenzo's Athena Countouriotis, and Biohaven's Vlad Coric on stage at the 2023 STAT Summit. STAT

What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars?

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology, which was acquired by Eli Lilly (where Van Naarden is now executive vice president) for $8 billion in 2019; and Athena Countouriotis, whose company Turning Point Therapeutics was acquired by BMS for $4 billion in 2022.

“Imagine you’re going through your typical day, and you get a message: Albert Bourla, chairman and CEO of Pfizer, wants to talk at six o’clock tonight,” said Coric, whose company had a successful migraine drug on the market and had just completed an IPO at the time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Telehealth startups turn to complex chronic diseases

WSS

Researchers on aging grapple with how to calculate biological age

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Dario to buy mental health app maker Twill in cash and stock deal

Medicare says breakthrough device reimbursement rule to come by summer

In utero gene editing: an explainer

Alabama IVF ruling threatens families facing fatal genetic disease

leisure time

comprehensive

explore

Medicare details structure of new drug price negotiation program

Readout LOUD podcast: What to know about H5N1 bird flu

Psychedelics group wrestles with new pharma identity

Making AI in medicine accessible to smaller, and rural hospitals

ChatGPT in medicine: STAT answers readers' burning questions

Readout LOUD podcast: What to know about H5N1 bird flu

Novavax promises a turnaround & Lilly roils the obesity market

Alabama frozen embryo ruling has major implications for IVF clinics

Anesthesiologist group: stop taking Ozempic before surgery

Steward Health Care files for bankruptcy

focus

6 phony surgeries that take placebo to the extreme

The Harvard botanist who searched for psychedelics in the Amazon

A new nitrogen execution bill also undermines medical licensing

The Harvard botanist who searched for psychedelics in the Amazon

Community Health Systems hospitals under DOJ investigation

Alabama frozen embryo ruling has major implications for IVF clinics

focus

leisure time

focus

knowledge